Continuous arteriovenous hemodialysis

Continuous arteriovenous hemodialysis CAVHD -h -h -h-l- -h Artery-vein Yes... 

Cj concentration of the drug in the plasma going into a Hlter Cjd plasma concentration after dialysis Cave average plasma concentration CAVH continuous arteriovenous hemoHltration CAVHD continuous arteriovenous hemodialysis CAVHDF continuous arteriovenous hemodiafiltration Cbo plasma concentration prior to the next dialysis session Cdf concentration of drug in the dialysis fluid equated total phenytoin concentration Cm total drug concentration measured in a patient with altered protein binding... 

Continuous arteriovenous hemodialysis and continuous venovenous hemodialysis can clear 60-85 L per day of lithium [119]. The main advantage of this treatment is that it decreases chances of hthium rebound. The disadvantages pertain to the fact that such continuous therapies do not reduce levels as quickly as hemodialysis and are often limited by the need for anticoagulation. 

Peritoneal dialysis Supplemental doses of valacyclovir should not be required following chronic ambulatory peritoneal dialysis (CARD) or continuous arteriovenous hemofiltration/hemodialysis (CAVHD). 

Peritoneal Dialyis There is no information specific to administration of VALTREX in patients receiving peritoneal dialysis. The effect of chronic ambulatory peritoneal dialysis (CARD) and continuous arteriovenous hemofiltration/dialysis (CAVHD) on acyclovir pharmacokinetics has been studied. The removal of acyclovir after CARD and CAVHD is less pronounced than with hemodialysis, and the pharmacokinetic parameters closely resemble those observed in patients with ESRD not receiving hemodialysis. Therefore, supplemental doses of VALTREX should not be required following CARD or CAVHD. 

In addition to patient-specific differences, there are marked differences between intermittent hemodialysis and the three primary types of CRRT continuous arteriovenous or venovenous hemofiltration (CAVH/CVVH), continuous arteriovenous or venovenous hemodialysis (CAVHD/CVVHD), and continuous arteriovenous or venovenous hemodiaflltration (CAVHDF/CVVHDF) with regard to drug removal." ... 

Key to abbreviations S = sustained-release formulations are available, and may lead to delayed absorption and prolonged effect HD = hemodialysis HP = hemoperfusion PD = peritoneal dialysis CHP = charcoal hemoperfusion MDAC = multiple dose activated charcoal CWHD = continuous veno venous hemodiafiltration CAVHD = continuous arteriovenous hemofiltration. 

---